Thursday, November 6, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Stock Picks

Strs Ohio Lowers Position in Nu Skin Enterprises, Inc. in Q1 2023 Amidst Revenue Decline

Roberto by Roberto
July 26, 2023
in Stock Picks
0
NUS stock news
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Nu Skin Enterprises Reports Lowered Position in Q1 2023

In a recent Securities and Exchange Commission (SEC) filing, it was revealed that Strs Ohio has decreased its stake in Nu Skin Enterprises, Inc. by 21.8% during the first quarter of 2023. According to the filing, Strs Ohio now owns 17,600 shares of the company’s stock, down from its previous ownership of 22,500 shares. Their holdings in Nu Skin Enterprises are estimated to be worth $691,000 based on the most recent quarter’s trading activity.

This revised position by Strs Ohio comes after the company’s quarterly earnings data was announced on May 3rd. Nu Skin Enterprises reported earnings per share (EPS) of $0.37 for the quarter, surpassing analysts’ consensus estimates by $0.04. The company’s return on equity stood at an impressive 14.13%, while their net margin was recorded at 3.68%. Despite beating expectations on EPS and showing solid financial performance overall, Nu Skin Enterprises experienced a decline in revenue with $481.50 million for the quarter, reflecting a decrease of 20.4% compared to the same period last year.

The lowered position by Strs Ohio may indicate a change in sentiment towards Nu Skin Enterprises among institutional investors like Strs Ohio itself. While the reasons behind this decision remain undisclosed, it is noteworthy that StockNews.com recently initiated coverage on Nu Skin Enterprises with a “hold” rating in a research note published on May 18th.

Analysts’ consensus rating for Nu Skin Enterprises is currently reported as “Hold,” according to Bloomberg data compiled as of July 24th, 2023. A consensus target price of $39.33 has also been set for the company’s stock.

Looking ahead, equities analysts anticipate that Nu Skin Enterprises will post strong earnings per share of around $2.61 for the full year 2023. This estimate takes into account the company’s ability to maintain its profitability and navigate any challenges or headwinds it may face in an ever-evolving market landscape.

Nu Skin Enterprises operates in the highly competitive beauty and wellness industry, offering a wide range of products marketed through direct selling. As consumer preferences shift and evolve, companies like Nu Skin Enterprises must adapt to changing trends and deliver innovative solutions to meet customer demands.

While Strs Ohio’s decision to lower its position in Nu Skin Enterprises raises questions and could be perceived as a cautious move, it does not necessarily imply negative sentiment towards the company as a whole. Investors should carefully monitor future developments within Nu Skin Enterprises and assess how it positions itself within the dynamic beauty and wellness industry.

Overall, despite facing some challenges in terms of revenue decline, Nu Skin Enterprises has demonstrated strong financial performance with exceeded EPS estimates. The lowered position by Strs Ohio serves as a reminder that investors should conduct thorough analysis before making investment decisions, taking into account various factors such as company performance, industry dynamics, and market conditions.

Disclaimer: The information provided in this article is based on publicly available data as of July 24th, 2023. Any opinions or predictions regarding future events or stock performance reflect the views of analysts at that time and are subject to change. Investors are advised to conduct their own research and consult with a financial advisor before making any investment decisions.
[bs_slider_forecast ticker=”NUS”]

Institutional Investors Show Strong Confidence in Nu Skin Enterprises with Notable Changes in Holdings

[stock_market_widget type=”chart” template=”basic” color=”#3946CE” assets=”NUS” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” api=”yf”]



Institutional investors have been making notable changes to their holdings in Nu Skin Enterprises (NYSE:NUS), according to recent reports. State Street Corp, for instance, increased its holdings in the company by a staggering 317.6% during the first quarter. The corporation now owns over 6.5 million shares of Nu Skin Enterprises’ stock, valued at approximately $312 million. Millennium Management LLC also saw a significant increase in its holdings, with a growth rate of 5,827.8% in the fourth quarter.

Norges Bank entered the scene as well, acquiring a new position in Nu Skin Enterprises worth $12.9 million during the same period. Invesco Ltd., another institutional investor, added an additional 286,628 shares to its portfolio during the first quarter. Finally, Morgan Stanley increased its stake by 20.5%, resulting in ownership of over 857,000 shares valued at $36 million.

Collectively, institutional investors now own a substantial 89.06% of Nu Skin Enterprises’ stock.

The market response to these developments was evident on Monday when shares of NYSE:NUS opened at $28.64. Interestingly enough, the stock’s performance has displayed volatility within this observation period—the highest recorded price was $47.31 while the lowest was $28.47.

As it stands, Nu Skin Enterprises boasts a market capitalization of $1.43 billion with an attractive price-to-earnings (P/E) ratio of 18.60 and a beta coefficient of 1.18—an indicator of volatility relative to the market as a whole.

In terms of liquidity ratios, Nu Skin Enterprises possesses a current ratio of 2.08 and quick ratio of 1.09—a reassuring sign for potential investors evaluating the company’s short-term financial health against liabilities.

Recent research notes from StockNews.com suggest that opinions regarding Nu Skin Enterprises are divided among industry experts. While the company received a “hold” rating by StockNews.com, other analysts on Bloomberg have assigned a consensus rating of “Hold” to the stock, with a consensus target price of $39.33.

Moreover, the company announced a quarterly dividend in June—an important consideration for yield-oriented investors. Shareholders of record on May 26th were granted a dividend of $0.39 per share. On an annualized basis, this represents a dividend yield of 5.45%. It is worth mentioning that the current dividend payout ratio stands at 101.30%.

In recent news related to Nu Skin Enterprises, Director Andrew D. Lipman conducted several significant transactions during June. On June 26th, he sold 2,000 shares at an average price of $32.12 per share. Furthermore, Director Edwina D. Woodbury sold 1,255 shares on May 9th at an average price of $37.87 per share.

These insider transactions highlight activities among prominent figures within the company and serve as potential indicators for investment decisions.

Overall, Nu Skin Enterprises has attracted the attention and interest of institutional investors who have made substantial changes to their holdings in recent months—a clear signal that confidence in the company’s growth potential remains high.

Tags: NUS
Roberto

Roberto

Related Posts

WM stock news
Stock Picks

Price T Rowe Associates Inc. MD Increases Holdings in Roper Technologies as Research Analysts Remain Optimistic

September 14, 2023
FLO stock news
Stock Picks

Mirova Acquires Position in ResMed Inc., Demonstrating Confidence in Growth Potential

September 14, 2023
AMT stock news
Stock Picks

Stock Update: Livforsakringsbolaget Skandia Omsesidigt Reduces Stake in Hewlett Packard Enterprise as Analyst Ratings Remain Mixed

September 13, 2023
Next Post
STRL stock news

Strs Ohio Decreases Stake in Sterling Infrastructure, Inc. as Prominent Construction Entity Continues to Thrive

JNJ stock news

PBMares Wealth Management LLC Increases Stake in Johnson & Johnson, Demonstrating Confidence in Growth Potential and Dividend Yield

PCOR stock news

Exploring the Future: Venturi Wealth Management LLC Invests in Procore Technologies, Inc. and the Rapid Advancements in Construction Technology

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recommended

Nuscale Power Stock

Nuscale Power Shares Surge on Monumental Nuclear Energy Agreement

2 months ago
FLO stock news

Cemtrex Shares Surge After Halting Trading Due to Circuit Breaker

2 years ago
Finance_ Chart Down

Discover the Top 3 Consumer Stocks with Impressive Dividend Yields Unveiled by Wall Streets Most Accurate Analysts

2 years ago
Eli Lilly Stock

Leadership Shift at Eli Lilly as Neuroscience Head Announces Departure

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Iovance Faces Critical Test as Q3 Earnings Approach

DuPont Faces Critical Test as Quarterly Results Loom

Sarepta Therapeutics Shares Plummet Following Critical Clinical Trial Failure

Emerson Electric’s Strategic Pivot Faces Market Scrutiny

EU Grant Provides Critical Boost for LanzaTech’s Carbon Recycling Technology

Is Darden Restaurants Facing a Critical Test?

Trending

Eastman Chemical Stock
Chemicals

Eastman Chemical’s Challenging Quarter: A Deep Dive into the Numbers

by Dieter Jaworski
November 6, 2025
0

Eastman Chemical Company finds itself navigating turbulent waters as the global specialty chemicals sector faces significant headwinds....

BioNTech Stock

BioNTech’s Crossroads: Navigating Losses Amid Cancer Research Promise

November 6, 2025
Illumina Stock

China Lifts Export Ban on Illumina’s DNA Sequencers, Sparking Market Rally

November 6, 2025
Iovance Stock

Iovance Faces Critical Test as Q3 Earnings Approach

November 6, 2025
DuPont de Nemours Stock

DuPont Faces Critical Test as Quarterly Results Loom

November 6, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Eastman Chemical’s Challenging Quarter: A Deep Dive into the Numbers
  • BioNTech’s Crossroads: Navigating Losses Amid Cancer Research Promise
  • China Lifts Export Ban on Illumina’s DNA Sequencers, Sparking Market Rally

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com